Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Bianca BerghuisJanic HulstAnja SonsmaMark McCormackGerrit-Jan de HaanJosemir W SanderDick LindhoutBobby P C KoelemanPublished in: Epilepsia (2021)
People with COIH had a 7-fold increased risk of developing adverse effects during treatment. Clinicians should consider ascertainment of sodium levels in patients taking CBZ and OXC and act upon findings.